XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 9,153,161 $ 4,046,937
Accounts receivable, net of allowance of $191 and $0 26,188 0
Unbilled accounts receivable 1,672,454 918,164
Other accounts receivable 308,374 0
Inventory 1,788,019 1,660,710
Investments 1,960,761 1,944,464
Prepaid expenses 130,170 153,455
Total Current Assets 15,039,127 8,723,730
Long-Term Assets:    
Equipment, net 140,857 143,079
Intangible asset, net 1,035,817 1,050,022
Total Long-Term Assets 1,176,674 1,193,101
Total Assets 16,215,801 9,916,831
Current Liabilities:    
Accounts payable and accrued expenses 868,000 1,449,582
Deferred revenue 205,109 200,109
Other liabilities 0 13,528
Total Current Liabilities 1,073,109 1,663,219
Total Liabilities 1,073,109 1,663,219
Stockholders' Equity    
Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock : 200,000,000 common shares authorized, par value $0.0001 per share, 128,840,421 and 126,702,545 shares outstanding at March 31, 2023 and December 31, 2022, respectively 12,883 12,669
Additional paid-in capital 24,619,639 16,110,221
Accumulated (deficit) (9,490,325) (7,849,982)
Accumulated other comprehensive loss 495 (19,296)
Total Stockholders' Equity 15,142,692 8,253,612
Total Liabilities and Stockholders' Equity $ 16,215,801 $ 9,916,831